Cases & Deals

Share

EDBI invests in Tessa Therapeutics

December 2017

Client(s) EDBI Pte Ltd

Jones Day represented EDBI Pte. Ltd. in connection with its affiliate's purchase of stock in a private placement by Tessa Therapeutics Pte. Ltd., an international clinical stage biopharmaceutical company focusing on T cell therapy for solid tumors. Temasek, Karst Peak Capital, Heliconia Capital Management, and Heritas acted as co-investors in the $80 million investment round.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.